GoodRx to be barred from sharing health data for ads under proposed FTC settlement
Summary
The Federal Trade Commission proposed to permanently bar prescription drug comparison site GoodRx from sharing users health data with third parties for advertising purposes, the agency said Wednesday. In a "first-of-its-kind proposed order," the FTC also said its imposing a $1.5 million civil penalty for allegedly violating the agencys Health Breach Notification Rule. For example, according to the FTC, GoodRx in 2019 uploaded to Facebook a list of information from users, who purchased certain medications, in order to target them with ads. GoodRx said in a blog post that medical records were not shared through its use of the Facebook pixel, the code websites use for advertising. FTC Commissioners voted 4-0 to refer the proposed order to the Department of Justice to file it on the FTCs behalf.